-
Electronic (PDF)
-
Site License
-
Enterprisewide
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
La Merie Publishing, February 2013, Pages: 35
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for treatment of infertility.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
1. FSH, hCG and LH - Therapeutic Proteins for ART
Urinary FSH-Containing Products: Menotropins 5
Recombinant Menotropins 7
1st Generation Purified Human Urinary FSH 8
2nd Generation Recombinant Human FSH 10
Biosimilar Recombinant Human FSH 11
2nd Generation Rhu FSH in Non-Regulated Markets 13
3rd Generation Rhu FSH 15
Purified Urinary Human Choriogonadotropin (hCG) 17
Recombinant Human Choriogonadotropin (rhCG) 20
Recombinant Human Luteinizing Hormone (rhLH) 21
hCG Receptor Agonist 22
Other 23
2. Corporate FSH, hCG and LH - Therapeutic Proteins for ART R&D Pipelines
Aeterna Zentaris 24
Alteogen 24
Amega Biotech 25
ASKA Pharmaceuticals 25
Bharat Biotech 25
BioGeneric Pharma 28
CinnaGen 29
Dong-A Pharmaceuticals 30
Ferring Pharmaceuticals 31
Finox Biotech 33
Genexine Co 33
Glycotope 34
Guangdong Techpool Bio-Pharma 34
IBSA Institut Biochimique SA 34
LG Life Science 35
Merck & Co. 36
Merck Serono 37
Mochida Pharmaceutical Co 40
Nippon Kayak 40
Pantec Biosolutions 41
Regeron 41
Reliance Life Science 42
Shionogi 43
Techpool Bio-Pharma 43
Teva Pharmaceutical Industries 44
Trophogen 45
Vaccines Ltd 45
Vyteris 46
Watson Pharmaceuticals 47
- Aeterna Zentaris
- Alteogen
- Amega Biotech
- ASKA Pharmaceuticals
- Bharat Biotech
- BioGeneric Pharma
- CinnaGen
- Dong-A Pharmaceuticals
- Ferring Pharmaceuticals
- Finox Biotech
- Genexine Co
- Glycotope
- Guangdong Techpool Bio-Pharma
- IBSA Institut Biochimique SA
- LG Life Science
- Merck & Co
- Merck Serono
- Mochida Pharmaceutical Co
- Nippon Kayak
- Pantec Biosolutions
- Regeron
- Reliance Life Science
- Shionogi
- Techpool Bio-Pharma
- Teva Pharmaceutical Industries
- Trophogen
- Vaccines Ltd
- Vyteris
- Watson Pharmaceuticals
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
